SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH BY NAME

BROWSE

Browse Australian listed companies0-9A BC DE FGH IJ KL MN OP QR ST UV WX YZ
Browse current Australian managed funds0-9A BCDE FGH IJKL MNOP QRST UVWX YZ

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

IMAGION BIOSYSTEMS LIMITED (IBX)

Listed on ASX ( $        )

Former (or subsequent) names

 

Shareholder links

Our website ranking of IBX: rating 3
(3 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Boardroom Pty Ltd, Level 12, 225 George Street, Sydney NSW 2000

Tel : +61 2 9290 9600 or 1300 737 760
Fax : +61 2 9279 0664 or 1300 653 459
RegistryWebsite RegistryEmail

Company details

Address: Level 8, 555 Bourke Street Melbourne Victoria 3000
Tel:  +1 505-243-1058 Fax: 

Date first listed: 22/06/2017
Company Secretary: Ms Jovanka Naumoska
Sector: Pharmaceuticals, Biotechnology & Life Sciences Industry Group: 
Activities: Research and development of medical diagnostics
The suspension of trading in the securities of Imagion Biosystems Limited will be lifted immediately, following the release by IBX of an announcement regarding a proposed capital raising. 20/09/2018
The company announces a pro-rata non-renounceable rights issue to shareholders on the basis of 1 new share for every 2 imagion shares held as at 7.00pm (Melbourne time) Friday 28 September 2018. The funds will finance the company's first in-human study for metastatic breast cancer and for general working capital. The rights issue will be for an issue price of $0.04 per share to raise up to $4.3 million. There will be a shortfall facility to enable applications for additional shares. 20/09/2018
The securities of Imagion Biosystems Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of IBX, pending the release of an announcement regarding a capital raising. 17/09/2018
listed entity carried for record purposes only22/06/2017

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    Posting your comments. Please wait...


    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    24/11/2017Robert Proulx235,000 $0.100$23,383

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Robert ProulxPresident, CEO22/06/2017
    Brian ConnCFO22/06/2017
    Bronwyn Le GriceNon Exec Director26/04/2018

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Peter Di ChiaraNon Exec Director28/04/201726/04/2018

    Date of first appointment, title may have changed.